Makers of OTC Medicines Recognize Gov. Brewer for Signing HB 2086

Arizona to be fifth state to limit sale of over-the-counter cough medicines containing dextromethorphan to minors

Washington, D.C. (April 30, 2014) — The Consumer Healthcare Products Association issued the following statement applauding Arizona Governor Jan Brewer for signing HB 2086 in to law.  HB 2086, sponsored by Representative Heather Carter, prohibits minors from purchasing over-the-counter (OTC) cough medicines containing dextromethorphan (DXM) without a prescription.

According to University of Michigan’s Monitoring the Future study,  approximately one in 25  teens abuses DXM  and other over-the-counter medicines to get high.

“The makers of over-the-counter medicines want to thank Governor Brewer, Representative Carter, and the Arizona legislature for taking a major step to address teen cough medicine abuse,” CHPA President and CEO Scott Melville said.

“The bill addresses the key issue of access – without access to these drugs – we can reduce the number of teens abusing these medicines. Our goal is to provide parents with the resources to keep their families safe and to raise awareness among other community stakeholders. We hope this accomplishment in Arizona will help generate further support for a national law,” said Carter.

Upon enactment of this bill, Arizona will be the fifth state to place an age-18 restriction on DXM sales. Louisiana and New Jersey are currently exploring similar legislation.

For more information on preventing teen abuse of OTC cough medicines, visit

Contact: Jenni Terry, 202.429.9260 

The Consumer Healthcare Products Association (CHPA) is the 133-year-old trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to promoting the increasingly vital role of over-the-counter medicines and dietary supplements in America’s healthcare system through science, education, and advocacy.